|1.||Park, Taesun: 1 article (01/2012)|
|2.||Choi, Miseon: 1 article (01/2012)|
|3.||Jung, Sung A: 1 article (01/2012)|
|4.||Kim, Sohee: 1 article (01/2012)|
|5.||Yu, Rina: 1 article (01/2012)|
|6.||Jeong, Soo-Jin: 1 article (08/2011)|
|7.||Lee, Hyo-Jeong: 1 article (08/2011)|
|8.||Ahn, Kwang Seok: 1 article (08/2011)|
|9.||Lee, Eun-Ok: 1 article (08/2011)|
|10.||Lee, Sang-Yun: 1 article (08/2011)|
|1.||Falciparum Malaria (Plasmodium falciparum Malaria)
01/01/2003 - "For cinchonine, values are likely to be within this range, but toxicological and pharmacokinetic studies on this compound are required for clarifying its potential future role in the treatment of falciparum malaria."
11/01/1989 - "Efficacy of a 3-day oral regimen of a quinine-quinidine-cinchonine association (Quinimax) for treatment of falciparum malaria in Madagascar."
01/01/1991 - "Red cell and plasma quinine-quinidine, and quinine concentrations in children with uncomplicated falciparum malaria who were treated with a combination of quinine/quinidine/cinchonine (combined drug) and quinine alone, respectively, were measured, using the extraction fluorescence method. "
09/01/1990 - "Thirteen patients with acute symptomatic uncomplicated falciparum malaria were enrolled in an open, randomized, phase 2, dose-finding clinical trial of a fixed dosage combination of quinine, quinidine and cinchonine (LA40221, Sanofi Recherche, France), which contained equal parts of the 3 alkaloids and was administered orally every 8 h in doses of 400 mg (7 patients) or 500 mg (6 patients) for 7 d. "
09/01/1990 - "Combination of quinine, quinidine and cinchonine for the treatment of acute falciparum malaria: correlation with the susceptibility of Plasmodium falciparum to the cinchona alkaloids in vitro."
01/01/2012 - "The main objective of this study was to investigate whether cinchonine reduces high-fat-diet- (HFD-) induced adipogenesis and inflammation in the epididymal fat tissues of mice and to explore the underlying mechanisms involved in these reductions. "
01/01/2012 - "Our findings suggest that dietary cinchonine with its effects on adipogenesis and inflammation may have a potential benefit in preventing obesity."
01/01/2012 - "Cinchonine Prevents High-Fat-Diet-Induced Obesity through Downregulation of Adipogenesis and Adipose Inflammation."
08/01/2004 - "Cinchonine (Cin) is the primary drug of choice in the treatment of malaria, but its poor solubility has restricted its use via the oral route. "
07/01/1946 - "Cinchonine in the treatment of malaria."
11/01/2004 - "The pharmacokinetics of increasing doses of an intrarectal Cinchona alkaloid combination containing 96.1% quinine, 2.5% quinidine, 0.68% cinchonine, and 0.67% cinchonidine (Quinimax) was compared to that of parenteral regimens in 60 children with moderate malaria. "
10/26/1918 - "THE ADVANTAGES OF INTRAMUSCULAR INJECTIONS OF SOLUBLE CINCHONINE SALTS IN SEVERE MALARIAL INFECTIONS."
11/01/1989 - "In the search for an effective, safe and field-adapted alternative to chloroquine for therapy of chloroquine-resistant Plasmodium falciparum infections in Africa, a 3-d oral regimen of Quinimax (an association of quinine, quinidine and cinchonine) was evaluated in 35 individuals with P. "
12/01/1992 - "Pharmacokinetics of quinine, quinidine and cinchonine when given as a combination were evaluated in Thai patients with falciparum malaria during acute infection and convalescence. "
|5.||Hematologic Neoplasms (Hematological Malignancy)
|8.||Nonesterified Fatty Acids (NEFA)